Elias Zambidis

Institute for Cell Engineering Johns Hopkins University School of Medicine, Baltimore, MD, United States 
"Elias Zambidis"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zimmerlin L, Angarita A, Park TS, et al. (2024) Proteogenomic Reprogramming to a Functional Human Totipotent Stem Cell State via a PARP-DUX4 Regulatory Axis. Biorxiv : the Preprint Server For Biology
Buys W, Zambidis ET. (2023) Harnessing bioengineered myeloid progenitors for precision immunotherapies. Npj Regenerative Medicine. 8: 66
Zimmerlin L, Park TS, Bhutto I, et al. (2022) Generation of Pericytic-Vascular Progenitors from Tankyrase/PARP-Inhibitor-Regulated Naïve (TIRN) Human Pluripotent Stem Cells. Methods in Molecular Biology (Clifton, N.J.). 2416: 133-156
Thomas J, Zimmerlin L, Huo JS, et al. (2021) Running the full human developmental clock in interspecies chimeras using alternative human stem cells with expanded embryonic potential. Npj Regenerative Medicine. 6: 25
Park TS, Zimmerlin L, Evans-Moses R, et al. (2020) Vascular progenitors generated from tankyrase inhibitor-regulated naïve diabetic human iPSC potentiate efficient revascularization of ischemic retina. Nature Communications. 11: 1195
Park TS, Zimmerlin L, Evans-Moses R, et al. (2018) Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency. Journal of Visualized Experiments : Jove
Zambidis E, Zimmerlin L, Park TS, et al. (2018) Human Pluripotent Stem Cells with Improved Functionality and Efficient Interspecies Chimera Potential Biology of Blood and Marrow Transplantation. 24: S476-S477
Zimmerlin L, Park TS, Zambidis ET. (2017) Capturing Human Naïve Pluripotency in the Embryo and in the Dish. Stem Cells and Development. 26: 1141-1161
Klein OR, Buddenbaum J, Tucker N, et al. (2016) Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation
Nagaria PK, Robert C, Park TS, et al. (2016) High-Fidelity Reprogrammed Human IPSCs Have a High Efficacy of DNA Repair and Resemble hESCs in Their MYC Transcriptional Signature. Stem Cells International. 2016: 3826249
See more...